Cargando…

Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver

Gene expression can be regulated by small non-coding RNA molecules like microRNAs (miRNAs) which act as cellular mediators necessary for growth, differentiation, proliferation, apoptosis, and metabolism. miRNA deregulation is often observed in many human malignancies, acting both as tumor-promoting...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandit, Anuradha, Begum, Yasmin, Saha, Priyanka, Srivastava, Amit Kumar, Swarnakar, Snehasikta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821656/
https://www.ncbi.nlm.nih.gov/pubmed/35145899
http://dx.doi.org/10.3389/fonc.2021.720622
_version_ 1784646447095873536
author Pandit, Anuradha
Begum, Yasmin
Saha, Priyanka
Srivastava, Amit Kumar
Swarnakar, Snehasikta
author_facet Pandit, Anuradha
Begum, Yasmin
Saha, Priyanka
Srivastava, Amit Kumar
Swarnakar, Snehasikta
author_sort Pandit, Anuradha
collection PubMed
description Gene expression can be regulated by small non-coding RNA molecules like microRNAs (miRNAs) which act as cellular mediators necessary for growth, differentiation, proliferation, apoptosis, and metabolism. miRNA deregulation is often observed in many human malignancies, acting both as tumor-promoting and suppressing, and their abnormal expression is linked to unrestrained cellular proliferation, metastasis, and perturbation in DNA damage as well as cell cycle. Matrix Metalloproteases (MMPs) have crucial roles in both growth, and tissue remodeling in normal conditions, as well as in promoting cancer development and metastasis. Herein, we outline an integrated interactive study involving various MMPs and miRNAs and also feature a way in which these communications impact malignant growth, movement, and metastasis. The present review emphasizes on important miRNAs that might impact gynecological cancer progression directly or indirectly via regulating MMPs. Additionally, we address the likely use of miRNA-mediated MMP regulation and their downstream signaling pathways towards the development of a potential treatment of gynecological cancers.
format Online
Article
Text
id pubmed-8821656
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88216562022-02-09 Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver Pandit, Anuradha Begum, Yasmin Saha, Priyanka Srivastava, Amit Kumar Swarnakar, Snehasikta Front Oncol Oncology Gene expression can be regulated by small non-coding RNA molecules like microRNAs (miRNAs) which act as cellular mediators necessary for growth, differentiation, proliferation, apoptosis, and metabolism. miRNA deregulation is often observed in many human malignancies, acting both as tumor-promoting and suppressing, and their abnormal expression is linked to unrestrained cellular proliferation, metastasis, and perturbation in DNA damage as well as cell cycle. Matrix Metalloproteases (MMPs) have crucial roles in both growth, and tissue remodeling in normal conditions, as well as in promoting cancer development and metastasis. Herein, we outline an integrated interactive study involving various MMPs and miRNAs and also feature a way in which these communications impact malignant growth, movement, and metastasis. The present review emphasizes on important miRNAs that might impact gynecological cancer progression directly or indirectly via regulating MMPs. Additionally, we address the likely use of miRNA-mediated MMP regulation and their downstream signaling pathways towards the development of a potential treatment of gynecological cancers. Frontiers Media S.A. 2022-01-25 /pmc/articles/PMC8821656/ /pubmed/35145899 http://dx.doi.org/10.3389/fonc.2021.720622 Text en Copyright © 2022 Pandit, Begum, Saha, Srivastava and Swarnakar https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Pandit, Anuradha
Begum, Yasmin
Saha, Priyanka
Srivastava, Amit Kumar
Swarnakar, Snehasikta
Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver
title Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver
title_full Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver
title_fullStr Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver
title_full_unstemmed Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver
title_short Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver
title_sort approaches toward targeting matrix metalloproteases for prognosis and therapies in gynecological cancer: micrornas as a molecular driver
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821656/
https://www.ncbi.nlm.nih.gov/pubmed/35145899
http://dx.doi.org/10.3389/fonc.2021.720622
work_keys_str_mv AT panditanuradha approachestowardtargetingmatrixmetalloproteasesforprognosisandtherapiesingynecologicalcancermicrornasasamoleculardriver
AT begumyasmin approachestowardtargetingmatrixmetalloproteasesforprognosisandtherapiesingynecologicalcancermicrornasasamoleculardriver
AT sahapriyanka approachestowardtargetingmatrixmetalloproteasesforprognosisandtherapiesingynecologicalcancermicrornasasamoleculardriver
AT srivastavaamitkumar approachestowardtargetingmatrixmetalloproteasesforprognosisandtherapiesingynecologicalcancermicrornasasamoleculardriver
AT swarnakarsnehasikta approachestowardtargetingmatrixmetalloproteasesforprognosisandtherapiesingynecologicalcancermicrornasasamoleculardriver